United States

Anhui Anke Biotechnology Group Co Ltd (300009.SZ)

300009.SZ on Shenzhen Stock Exchange

9 Dec 2016
Change (% chg)

¥-0.05 (-0.22%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 300009.SZ


ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD. is principally engaged in the research, development, manufacture and distribution of biological products, Chinese medicines and synthetic drugs. Its biological products include recombinant human interferon alfa-2b injection, recombinant human interferon alfa-2b suppository, recombinant... (more)


Beta: 0.82
Market Cap(Mil.): ¥12,446.98
Shares Outstanding(Mil.): 547.60
Dividend: 0.12
Yield (%): 0.51


  300009.SZ Industry Sector
P/E (TTM): 67.39 41.98 30.40
EPS (TTM): 0.34 -- --
ROI: 15.00 -0.36 15.24
ROE: 15.90 -0.94 16.58

BRIEF-Anhui Anke Biotechnology Group plans gene tech JV with partner

* Says it plans to set up a gene tech JV in Hefei city, with an individual Pu Yi

Nov 16 2016

BRIEF-Anhui Anke Biotechnology Group sets up med lab in Hefei city

* Says it sets up a med lab as wholly-owned subsidiary in Hefei city with investment of 23 million yuan

Nov 11 2016

BRIEF-Anhui Anke Biotechnology (Group) plans cell tech JV with PersonGen Biomedicine (Suzhou)

Oct 28 Anhui Anke Biotechnology (Group) Co Ltd :

Oct 28 2016

BRIEF-Anhui Anke Biotechnology sees 2016 Q1 to Q3 net profit up 27.6-38.6 pct

Oct 17 Anhui Anke Biotechnology (Group) Co., Ltd. :

Oct 17 2016

BRIEF-Anhui Anke Biotechnology Group to invest 30 mln yuan in biotechnology firm

* Says it to invest 30 million yuan in a Shanghai-based biotechnology firm

Sep 20 2016

BRIEF-Anhui Anke Biotechnology Group buys Wuxi-based co

* Says it acquired 100 percent stake in a Wuxi-based biotechnology co

Jun 27 2016

Earnings vs. Estimates